| Edward P Junkins Jr, MD | |
|
200 Mullins Dr, Lebanon, OR 97355-3983 | |
| (541) 259-0200 | |
| Not Available |
| Full Name | Edward P Junkins Jr |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 200 Mullins Dr, Lebanon, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144301938 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0204X | Pediatrics - Pediatric Emergency Medicine | 341811-1205 (Utah) | Secondary |
| 2080P0204X | Pediatrics - Pediatric Emergency Medicine | MD162985 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Edward P Junkins Jr, MD 200 Mullins Dr, Lebanon, OR 97355-3983 Ph: (541) 259-0200 | Edward P Junkins Jr, MD 200 Mullins Dr, Lebanon, OR 97355-3983 Ph: (541) 259-0200 |
News Archive
Politico reports on efforts to sign people up for health care as Humana sends a lime green bus through some of the state's poorest areas. Other outlets look at enrollment campaigns in Maine, California, Connecticut, Minnesota, Oregon and Colorado.
Bristol-Myers Squibb Company and AbbVie today announced that the U.S. Food and Drug Administration (FDA) has granted elotuzumab, an investigational humanized monoclonal antibody, Breakthrough Therapy Designation for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have received one or more prior therapies.
Rally Foundation, a national non-profit organization committed to research to fight childhood cancer, has announced its annual funding allocation for 2011 and has selected 15 hospitals across the country to receive more than $700,000.
Children born after assisted reproductive technology do not appear to be at greater risk of developing cancer than other children, according to the first study to look at the long-term cancer risk in ART children compared to those in the general population or who were naturally conceived by subfertile women.
In the United States Clostridium difficile or "C. difficile" is now recognized as one of the most dangerous and fastest growing Healthcare Acquired Infections (HAIs) in existence. Now surpassing even Staphylococcus aureus (MRSA), C. difficile infections tripled between 2000 and 2005.
› Verified 4 days ago
Dr. Thurman Allen Merritt, Pediatrics Medicare: Medicare Enrolled Practice Location: 701 N 5th St Unit C1020, Lebanon, OR 97355 Phone: 541-451-7820 Fax: 541-451-7236 | |
Dr. Shi H. Lee, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Twin Oaks Ave, Suite A-2, Lebanon, OR 97355 Phone: 541-451-7820 Fax: 541-451-7236 | |
Dr. Richard Howell Ames, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 675 N 5th St Ste 200, Lebanon, OR 97355 Phone: 541-451-6282 | |
Dr. Robert Paulsen Michael, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 675 N 5th St, Lebanon, OR 97355 Phone: 541-451-6282 Fax: 541-812-2038 | |
Carolina Del Socorro Amador, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 675 N 5th St Ste 200, Lebanon, OR 97355 Phone: 541-451-6282 |